AMAN

10.0900.10%
WB

W. Bradford Middlekauff

Independent Director

Mr. W. Bradford Middlekauff, also known as Brad, is Independent Director of Amanat Acquisition Corp from May 18, 2026. He served as Chief Legal Officer at Castle Creek Biosciences, Inc. since May 2021 until August 2023 and served as its Secretary. He served as Chief Business Officer, General Counsel & Corporate Secretary at Tourmaline Bio, Inc until October 28, 2025. He serves on the Board of Directors of ProteoDesign, S.L. Mr. Middlekauff was the General Counsel of Immunovant, Inc. since April 2019 until 2020. From October 2015 to April 2019, he served as Senior Vice President, General Counsel and Secretary of PDS Biotechnology Corporation (formerly known as Edge Therapeutics, Inc.). From October 2014 to October 2015, Mr. Middlekauff was Executive-in-Residence at Princeton University. Mr. Middlekauff served as the Chief Legal Officer, General Counsel and Secretary of Kolltan Pharmaceuticals, Inc. from December 2008 to August 2013. He served as Senior Vice President of Strategic Planning at Medarex, Inc. since November 15, 2007. He also served as Senior Vice President, General Counsel and Secretary of Medarex Inc. from March 2000 to November 15, 2007. He joined Medarex Inc. in March 2000. He served as Vice President of Business Development and General Counsel at Algos Pharmaceutical Corporation from August 1998 to February 2000. He joined Algos Pharmaceutical Corp. in 1998. From September 1993 to July 1998, he served as an Associate with the law firm of Cooley Godward LLP, where he advised life science companies on business and legal aspects of research and development, corporate partnering and licensing, product commercialization and corporate financing. Mr. Middlekauff earned a B.A. in Political Science from Brown University and a J.D. from Yale Law School.

Positions